The DOI matches its Crossref record; 11 of the 11 references it cites were found in a registry or an index.
Likelihood of seizure remission in an adult population with refractory epilepsy
Abstract
Objective: We aimed to determine the likelihood of remission and its clinical predictors in adult patients meeting a strict definition of refractory epilepsy. We also wanted to investigate the influence of treatment regimen on remission. Methods: A total of 246 patients with treatment refractory epilepsy (having at least 1 seizure per month and having not responded positively to at least 2 antiepileptic drugs) were identified in 2000 and followed for 3 years. We used Kaplan–Meier methods to estimate the rate of achieving a 6‐month terminal seizure remission and Cox regression analysis to evaluate clinical predictors for seizure remission. Results: The estimated 6‐month terminal seizure remission rate was 19% (95% confidence interval, 14–26%) for all cases and 14% (95% confidence interval, 10–21%) when limited to those treated only with medication. Negative predictors for remission included a history of status epilepticus, younger age at intractability, number of failed drug therapies, and presence of mental retardation. No specific drug was significantly associated with remission, and frequently, no clear intervention led to terminal remission. Interpretation: Fifteen percent (approximately 5% per year) of a drug refractory epilepsy population obtained a 6‐month terminal seizure remission. Our results signify that no matter how many antiepileptic drug therapies have failed, there is always hope of a meaningful seizure remission in this population. Furthermore, we have elucidated four clinical predictors that can aid the epileptologist in prognostication. Ann Neurol 2007
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Early Identification of Refractory Epilepsy
Kwan, P., & Brodie, M. J. (2000) · New England Journal of Medicine · doi:10.1056/nejm200002033420503 · Cited by 5,204
Is the underlying cause of epilepsy a major prognostic factor for recurrence?
Semah, F., Picot, M.-C., Adam, C., Broglin, D., Arzimanoglou, A., Bazin, B., Cavalcanti, D., & Baulac, M. (1998) · Neurology · doi:10.1212/wnl.51.5.1256 · Cited by 1,113
Predictors of Intractable Epilepsy in Childhood: A Case‐Control Study
Berg, A. T., Levy, S. R., Novotny, E. J., & Shinnar, S. (1996) · Epilepsia · doi:10.1111/j.1528-1157.1996.tb00507.x · Cited by 226
Risk of Recurrence After an Initial Unprovoked Seizure
Annegers, J. F., Shirts, S. B., Hauser, W. A., & Kurland, L. T. (1986) · Epilepsia · doi:10.1111/j.1528-1157.1986.tb03499.x · Cited by 211
Self-citationRemission of Seizures and Predictors of Intractability in Long‐Term Follow‐Up
Sillanpää, M. (1993) · Epilepsia · doi:10.1111/j.1528-1157.1993.tb02114.x · Cited by 210
A follow‐up study of intractable seizures in childhood
Huttenlocher, P. R., & Hapke, R. J. (1990) · Annals of Neurology · doi:10.1002/ana.410280516 · Cited by 192
Response to first drug trial predicts outcome in childhood temporal lobe epilepsy
Dlugos, D. J., Sammel, M. D., Strom, B. L., & Farrar, J. T. (2001) · Neurology · doi:10.1212/wnl.57.12.2259 · Cited by 169
Commission on European Affairs: Appropriate Standards of Epilepsy Care Across Europe
Brodie, M. J., Shorvon, S. D., Canger, R., Halász, P., Johannessen, S. I., Thompson, P. J., Wieser, H. G., & Wolf, P. (1997) · Epilepsia · doi:10.1111/j.1528-1157.1997.tb01224.x · Cited by 149
Antiepileptic Drug Therapy: When Is Epilepsy Truly Intractable?
CAMFIELD, P. R., & Camfield, C. (1996) · Epilepsia · doi:10.1111/j.1528-1157.1996.tb06023.x · Cited by 115
Is Refractory Epilepsy Preventable?
Arroyo, S., Brodie, M. J., AVANZINI, G., Baumgartner, C., Chiron, C., Dulac, O., French, J. A., & Serratosa, J. M. (2002) · Epilepsia · doi:10.1046/j.1528-1157.2002.38501.x · Cited by 90
Self-citation
Cited by
Kwan, P., Arzimanoglou, A., Berg, A. T., Brodie, M. J., Allen Hauser, W., Mathern, G., Moshé, S. L., Perucca, E., Wiebe, S., & French, J. (2010) · Epilepsia · doi:10.1111/j.1528-1167.2009.02397.x · Cited by 4,877
Self-citationPatterns of treatment response in newly diagnosed epilepsy
Brodie, M. J., Barry, S. J. E., Bamagous, G. A., Norrie, J. D., & Kwan, P. (2012) · Neurology · doi:10.1212/wnl.0b013e3182563b19 · Cited by 931
Modern antiepileptic drug development has failed to deliver: Ways out of the current dilemma
Löscher, W., & Schmidt, D. (2011) · Epilepsia · doi:10.1111/j.1528-1167.2011.03024.x · Cited by 590
Key factors in the discovery and development of new antiepileptic drugs
Bialer, M., & White, H. S. (2010) · Nature Reviews Drug Discovery · doi:10.1038/nrd2997 · Cited by 542
Intractable epilepsy: management and therapeutic alternatives
Schuele, S. U., & Lüders, H. O. (2008) · The Lancet Neurology · doi:10.1016/s1474-4422(08)70108-x · Cited by 344
Metadata
- Authors
- Callaghan, B. C., Anand, K., Hesdorffer, D., Hauser, W. A., & French, J. A.
- Venue
- Annals of Neurology
- Publisher
- Wiley
- Published
- 2007-10
- Volume
- 62
- Issue
- 4
- Pages
- 382-389
- ISSN
- 0364-5134 (ISSN-L)
- 1531-8249
- OpenAlex
- W2083785141
- Cited by
- 312
- References
- 11
- FWCI
- 12.01
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Likelihood of seizure remission in an adult population with refractory epilepsy. https://app.cochat.ai/papers/10.1002/ana.21166
- The paper
- Callaghan, B. C., Anand, K., Hesdorffer, D., Hauser, W. A., & French, J. A. (2007). Likelihood of seizure remission in an adult population with refractory epilepsy. Annals of Neurology. https://doi.org/10.1002/ana.21166
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.